Japan Tissue Engineering Co (TSE:7774) Common Stock: 円3,998 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:7774 Japan Tissue Engineering Co Ltd TSE:7774
61 GF Score
Price 円621.00
GF Value 円517.48
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is Japan Tissue Engineering Co Common Stock?

Japan Tissue Engineering Co TSE:7774 -4.90% 61 Common Stock is 円3,998 Mil as of Mar. 2026. GuruFocus rates TSE:7774 with a GF Score™ of 61/100 and a GF Value™ of 円517.48 (Modestly Overvalued). The stock has 2 warning signs investors should review.

Japan Tissue Engineering Co's quarterly common stock declined from Mar. 2025 (円4,959 Mil) to Sep. 2025 (円3,998 Mil) but then stayed the same from Sep. 2025 (円3,998 Mil) to Mar. 2026 (円3,998 Mil).

Japan Tissue Engineering Co's annual common stock stayed the same from Mar. 2024 (円4,959 Mil) to Mar. 2025 (円4,959 Mil) but then declined from Mar. 2025 (円4,959 Mil) to Mar. 2026 (円3,998 Mil).

Japan Tissue Engineering Co Common Stock Historical Data

* Premium members only.

The historical data trend for Japan Tissue Engineering Co's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Japan Tissue Engineering Co Common Stock Chart

Japan Tissue Engineering Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,958.76 4,958.76 4,958.76 4,958.76 3,997.67

Japan Tissue Engineering Co Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,958.76 4,958.76 4,958.76 3,997.67 3,997.67
TSE:7774
61GF Score
Japan Tissue Engineering Co Ltd TSE:7774
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Japan Tissue Engineering Co Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of 円3,998 Mil mean?
Japan Tissue Engineering Co (TSE:7774) has a Common Stock of 円3,998 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Japan Tissue Engineering Co and its competitors.
Is Japan Tissue Engineering Co's Common Stock too high?
Japan Tissue Engineering Co's current Common Stock is 円3,998 Mil. Overall, Japan Tissue Engineering Co has a GF Score™ of 61/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Japan Tissue Engineering Co's Common Stock compare to VRTX and REGN?
Japan Tissue Engineering Co's Common Stock of 円3,998 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Japan Tissue Engineering Co and its competitors. Japan Tissue Engineering Co's current Common Stock is 円3,998 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Japan Tissue Engineering Co stock overvalued right now?
Based on GuruFocus' analysis, Japan Tissue Engineering Co (TSE:7774) is currently considered Modestly Overvalued. The stock's GF Value™ is 円517.48, compared to a current price of 円621.00 — trading 20% above its estimated fair value. The current Common Stock is 円3,998 Mil. Japan Tissue Engineering Co's overall GF Score™ is 61/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Japan Tissue Engineering Co (TSE:7774), the current Common Stock is 円3,998 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Japan Tissue Engineering Co (TSE:7774) Overvalued in 2026?

Based on GuruFocus' analysis, Japan Tissue Engineering Co stock appears to be overvalued. The current stock price of 円621.00 is trading 20% above its estimated GF Value™ of 円517.48. GuruFocus considers Japan Tissue Engineering Co to be Modestly Overvalued.

Key valuation signals for TSE:7774:

  • Common Stock: 円3,998 Mil
  • GF Value™: 円517.48 vs. price of 円621.00 (20% above fair value)
  • GF Score™: 61/100 with 2 warning signs

No single metric tells the full story. See the TSE:7774 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Japan Tissue Engineering Co Business Description

Address 6-209-1 Miyakitadori, Gamagori, Aichi, JPN, 443-0022
Japan Tissue Engineering Co Ltd is a bio-venture enterprise. It is engaged in the development, manufacture, and sale of tissue-engineered medical products and related products. It operates through the Regenerative Medicine, and Research and Development support business segments. The main business goal is to use autologous culturing techniques to develop tissue-engineered medical products and then to manufacture and sell these same tissue-engineered products to medical institutions for medical treatment. The company's tissue-engineered medical products are used in autologous transplant cases, where living cells are taken from the actual patient himself, cultured and then transplanted back to that same patient.
61GF Score

Get the complete analysis for TSE:7774

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円621.00
Price
円517.48
GF Value